PHARMACOECONOMIC IMPACT OF POST–DEEP BRAIN STIMULATION MEDICATION USE AND ADVERSE EVENT PROFILE IN PATIENTS WITH PARKINSON’S DISEASE IN PAKISTAN. FMHR 2026, 4 (6), 320-330.